Scientific Online Resource System

Biomedical Reviews

Subependymal Gian Cell Astrocytoma in An Adult Without Tuberous Sclerosis Complex: A Neuropathologial Case Report of a Tumor Initially Misdiagnosed as Glioblastoma

George S. Stoyanov

Abstract

Subependymal giant cell astrocytomas (SEGA) are WHO CNS grade 1 tumors, predominantly diagnosed in the pediatric and young adult populations and almost always encountered in the context of the tuberous sclerosis complex (TSC). SEGAs develop from subependymal nodular (SEN), which are a component of TSC, while both have similar radiological and histological. Char-acteristically, SEN are small lesions that are growth stable and typically do not produce symptoms, while SEGAs are steadily growing lesions that produce compression-associated symptoms due to their periventricular location. Histologically, SEGAs present with pleomorphic, epitheloid-like, and giant multinucleated cells, with other glial phenotypes such as pyloid, histiocytic, and others also present. Tumors are sharply demarcated from the surrounding parenchyma and, other than the striking cellular appearance, may also show areas of palisading necrosis, making the histopathological diagnosis challenging. In cases of older patients or when a history of TSC is either not present or not known by the neuropathologist, the differential diagnosis can be quite challenging and includes a myriad of either lower-grade neuroglial tumors as well as high-grade astrocytic ones. Herein, we present a neuropathological case report of a 63-year-old female with no known TSC history and a CNS tumor with morpho-logical characteristics of SEGA.

Keywords

neuropathology, astroglial tumors, subependymal giant cell astrocytoma, glioblastoma, tuberous sclerosis

Full Text


References

Lopes MBS, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characteriza-tion of subependymal giant cell astrocytomas. Acta Neu-ropathol 1996;91:368–75. DOI:10.1007/S004010050438

Mei GH, Liu XX, Zhou P, Shen M. Clinical and imag-ing features of subependymal giant cell astrocytoma: Report of 20 cases. Chinese Neurosurg J 2017; 3:1–7. 1DOI:10.1186/S41016-017-0077-4/FIGURES/3

Beaumont TL, Godzik J, Dahiya S, Smyth MD. Sub-ependymal giant cell astrocytoma in the absence of tuber-ous sclerosis complex: case report. J Neurosurg Pediatr. 2015; 16:134–7. DOI:10.3171/2015.1.PEDS13146

Bongaarts A, Giannikou K, Reinten RJ, et al. Subependy-mal giant cell astrocytomas in Tuberous Sclerosis Com-plex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations. Oncotarget 2017; 8:95516–29. DOI:10.18632/ONCOTARGET.20764

Goh S, Butler W, Thiele EA.: Subependymal gi-ant cell tumors in tuberous sclerosis complex. Neu-rology 2004; 63:1457–61. DOI:10.1212/01. WNL.0000142039.14522.1A

Clarke MJ, Foy AB, Wetjen N, Raffel C: Imaging characteristics and growth of subependymal giant cell astrocytomas. Neurosurg Focus. 2006; 20. DOI:10.3171/FOC.2006.20.1.6

Borkowska J, Schwartz RA, Kotulska K, Jozwiak S. Tuberous sclerosis complex: tumors and tumorigenesis. Int J Dermatol. 2011; 50:13–20. DOI:10.1111/J.1365-4632.2010.04727.X

Magri L, Cambiaghi M, Cominelli M, et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell. 2011; 9:447–62. DOI:10.1016/J.STEM.2011.09.008

Franz DN, Belousova E, Sparagana S, et al. Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study. PLoS One. 2016, 11. DOI: 10.1371/JOURNAL.PONE.0158476

Roth J, Roach ES, Bartels U, et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol. 2013, 49:439–44. DOI:10.1016/J.PEDIATRNEU-ROL.2013.08.017

Telfeian AE, Judkins A, Younkin D, Pollock AN, Crino P: Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Case report. J Neurosurg. 2004, 100:498–501. DOI:10.3171/PED.2004.100.5.0498

Aguilera D, Flamini R, Mazewski C, et al. Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus. J Pediatr Hematol Oncol. 2014, 36:e448–51. DOI:10.1097/MPH.0000000000000005

Campen CJ, Porter BE: Subependymal giant cell astro-cytoma (SEGA) treatment update. Curr Treat Options Neurol. 2011, 13:380–5. 10.1007/s11940-011-0123-z

Li M, Zhou Y, Chen C, et al. Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: A meta-analysis. Orphanet J Rare Dis. 2019, 14:1–9. 10.1186/S13023-019-1012-X/FIGURES/7

Glioblastoma, IDH-wildtype. WHO Classif. tumors on-line, Cent. Nerv. Syst. tumors 5th ed. (2021). Accessed: December 21, 2022. https://tumourclassification.iarc.who. int/chaptercontent/45/7.

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23:1231–51. DOI:10.1093/NEUONC/NOAB106




DOI: http://dx.doi.org/10.14748/bmr.v34.9617

Refbacks

Article Tools
Email this article (Login required)
About The Author

George S. Stoyanov

Font Size


|